|
1.
Share Success: Letters From Readers
Letter I: From Evelyn W.
Received
at Customer Service (customerservice @ ezorbonline.com) Thu, Jan 30 at 3:41 PM
(Unedited)
Both my husband and I have had marvelous success with ezorb! We are BOTH walking without pain and my husband's bone spurs were GONE within a month!
We started on Ezorb about 12 years ago and wouldn't be without it now!
My question now: My brother in law has been diagnosed with pulmonary fibrosis. He suffers greatly with pain and difficult breathing. Do you think your Marvlix could help? His condition is not mentioned in your literature.
Thanks for your reply.
Letter II: From Veronica D., Irvine, CA
Received
at Testimonial Submit Form Wed, Feb 5, 2020 at 12:03 PM
(Unedited)
Hi my name is Veronica D.
My mother has been taking EZorb for over a year. She was diagnosed of osteoporosis in December 2018. Her doctor wanted to put her on Fosamax. I said hell no. I researched online and got her on EZorb.
I have great news to report. My mom's lumbar spine went up 6.2% in bone density. Her left hip numbers didn't change much however. Considering her numbers had kept going downhill for 3 years before EZorb, a no-change is actually quite good.
Thank you EZorb.
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 120,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. We appreciate your effort.
2.
Research News: Hypoglycemia Linked to Renal Dysfunction
A large observational study reveals a strong link between reduced kidney function and increased incidence of hypoglycemia in adults with diabetes in routine clinical practice.
"Our study underlines the need for greater provider awareness and regular monitoring of kidney function in patients with diabetes, in accordance with current ADA recommendations," write the study authors in Diabetes, Obesity and Metabolism.
Bjorn Runesson (Karolinska University Hospital, Stockholm, Sweden) and co-researchers note that routine monitoring of estimated glomerular filtration rate (eGFR) is "often suboptimal." Yet they say their findings suggest an increased hypoglycemia risk even at "mild eGFR reductions."
The team studied 29,434 people with type 1 or 2 diabetes who accessed healthcare in the Stockholm region during 2006-2011. They were a median age of 66 years, 43% were female, and 13.4% had type 1 diabetes.
During a median 2 years of follow-up, 6.2% of the cohort had at least one documented hypoglycemic episode, with the unadjusted rate increasing across decreasing categories of eGFR, from 3.9% to 32.0% for eGFR categories of 90-104 versus less than 15 mL/min per 1.73 m2.
Compared with people in the 90-104 mL/min per 1.73 m2 eGFR category, those with even mild kidney impairment (eGFR 60-89 mL/min per 1.73 m2) had a significantly increased risk for mild hypoglycemia, at an incidence rate ratio (IRR) of 1.3 after adjustment for multiple variables including diabetes type and complications, comorbidities, medications, glycated hemoglobin level, and previous healthcare use.
For moderate or severe hypoglycemia, the risk became significantly increased at an eGFR of 45-59 mL/min per 1.73 m2, at an IRR of 1.5 versus the reference category. The IRRs for hypoglycemia in people with an eGFR below 15 mL/min per 1.73 m2 were 9.5 for mild and 4.2 for moderate or severe events.
There was also a hint of increased hypoglycemia risk (nonsignificant) in people with renal function greater than 104 mL/min per 1.73 m2, which the team suggests may reflect early renal dysfunction in the form of hyperfiltration.
Reduced kidney function was additionally associated with an increased risk for mortality within 30 days after a hypoglycemic event, although this was significant only for those with markedly reduced eGFR of less than 30 mL/min per 1.73 m2.
The researchers identified "numerous baseline predictors of hypoglycemia" besides renal function, including age, medications (insulins and sulfonylureas), and various complications and comorbidities, which they suggest may "represent a non-specific relationship between hypoglycemia and poor health."
Indeed, they caution that, despite the existence of many plausible mechanisms by which impaired renal function could increase hypoglycemia risk, kidney disease usually occurs in the context of multiple morbidity, and so "it is also possible that the associations observed simply reflect underlying disease or duration of diabetes and insulin use."
Original article was published in Diabetes Obes Metab 2020; doi:10.1111/dom.14051.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
